Log in

USANA Health Sciences Stock Price, Forecast & Analysis (NYSE:USNA)

$71.85
-0.25 (-0.35 %)
(As of 11/19/2019 03:03 AM ET)
Today's Range
$71.79
Now: $71.85
$73.12
50-Day Range
$67.02
MA: $71.82
$79.23
52-Week Range
$58.30
Now: $71.85
$125.61
Volume81,924 shs
Average Volume237,432 shs
Market Capitalization$1.56 billion
P/E Ratio13.92
Dividend YieldN/A
Beta0.28
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition. Read More…

Industry, Sector and Symbol

Industry Medicinals & botanicals
Sub-IndustryPersonal Products
SectorMedical
CUSIP90328M10
Phone801-954-7100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.19 billion
Cash Flow$5.98 per share
Book Value$14.52 per share

Profitability

Net Income$126.22 million

Miscellaneous

Employees1,911
Market Cap$1.56 billion
Next Earnings Date2/4/2020 (Estimated)
OptionableOptionable

Receive USNA News and Ratings via Email

Sign-up to receive the latest news and ratings for USNA and its competitors with MarketBeat's FREE daily newsletter.


USANA Health Sciences (NYSE:USNA) Frequently Asked Questions

What is USANA Health Sciences' stock symbol?

USANA Health Sciences trades on the New York Stock Exchange (NYSE) under the ticker symbol "USNA."

How will USANA Health Sciences' stock buyback program work?

USANA Health Sciences announced that its Board of Directors has approved a share repurchase program on Tuesday, October 23rd 2018, which authorizes the company to repurchase $150,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to buy up to 5.9% of its stock through open market purchases. Stock repurchase programs are typically a sign that the company's leadership believes its shares are undervalued.

How were USANA Health Sciences' earnings last quarter?

USANA Health Sciences, Inc. (NYSE:USNA) released its earnings results on Tuesday, October, 22nd. The company reported $1.09 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.87 by $0.22. The business had revenue of $260.60 million for the quarter, compared to the consensus estimate of $256.22 million. USANA Health Sciences had a return on equity of 27.60% and a net margin of 9.38%. USANA Health Sciences's quarterly revenue was down 12.2% compared to the same quarter last year. During the same quarter last year, the business earned $1.24 earnings per share. View USANA Health Sciences' Earnings History.

When is USANA Health Sciences' next earnings date?

USANA Health Sciences is scheduled to release their next quarterly earnings announcement on Tuesday, February 4th 2020. View Earnings Estimates for USANA Health Sciences.

What guidance has USANA Health Sciences issued on next quarter's earnings?

USANA Health Sciences issued an update on its FY19 earnings guidance on Tuesday, October, 22nd. The company provided EPS guidance of $3.90-4.05 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.79. The company issued revenue guidance of $1.030-1.045 billion, compared to the consensus revenue estimate of $1.04 billion.

What price target have analysts set for USNA?

4 brokerages have issued 1-year price objectives for USANA Health Sciences' stock. Their forecasts range from $65.00 to $75.00. On average, they anticipate USANA Health Sciences' share price to reach $70.00 in the next twelve months. This suggests that the stock has a possible downside of 2.6%. View Analyst Price Targets for USANA Health Sciences.

What is the consensus analysts' recommendation for USANA Health Sciences?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for USANA Health Sciences in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for USANA Health Sciences.

What are Wall Street analysts saying about USANA Health Sciences stock?

Here are some recent quotes from research analysts about USANA Health Sciences stock:
  • 1. According to Zacks Investment Research, "USANA Health Sciences Inc. develops and manufactures high-quality nutritional, personal care and weight management products. The company's three primary product lines consist of nutritional, personal care and weight management products. The company's products are distributed primarily through a network marketing system. " (10/26/2019)
  • 2. Pivotal Research analysts commented, "We thought it noteworthy that the company projected average diluted shares outstanding of 22.7 million, given that 2Q diluted shares out were 23.4 million. To get to that average we expect the company will need to buy-in 1.9 million shares in the 2H. That will put average shares outstanding down 7.7% for the year. This is not so important for 2019, but it will be for next year when we see an earnings recovery of 27% at the net income line (still below 2018) but EPS growth of 38% owing to the reduced share count." (7/24/2019)

Has USANA Health Sciences been receiving favorable news coverage?

News articles about USNA stock have been trending extremely negative on Tuesday, InfoTrie Sentiment reports. The research firm identifies positive and negative media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. USANA Health Sciences earned a coverage optimism score of -4.6 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for USANA Health Sciences.

Who are some of USANA Health Sciences' key competitors?

What other stocks do shareholders of USANA Health Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other USANA Health Sciences investors own include Allergan (AGN), Tableau Software (DATA), IBM (IBM), Amgen (AMGN), bluebird bio (BLUE), BioMarin Pharmaceutical (BMRN), Celgene (CELG), Gilead Sciences (GILD), Intel (INTC) and Abbott Laboratories (ABT).

Who are USANA Health Sciences' key executives?

USANA Health Sciences' management team includes the folowing people:
  • Dr. Myron W. Wentz, Founder & Chairman (Age 78)
  • Mr. Kevin G. Guest, CEO & Director (Age 56)
  • Mr. Jim Brown, Pres & COO (Age 50)
  • Mr. G. Douglas Hekking, Chief Financial Officer (Age 49)
  • Mr. Walter Noot, Chief Information Officer (Age 53)

Who are USANA Health Sciences' major shareholders?

USANA Health Sciences' stock is owned by many different of institutional and retail investors. Top institutional investors include Russell Investments Group Ltd. (0.55%), Robeco Institutional Asset Management B.V. (0.49%), Rhumbline Advisers (0.18%), State of New Jersey Common Pension Fund D (0.17%), 6 Meridian (0.15%) and California Public Employees Retirement System (0.11%). Company insiders that own USANA Health Sciences stock include Daniel A Macuga, David Mulham Mulham, Feng Peng, Frederic J Winssinger, G Doug Iiekking, Gilbert A Fuller, Global Ltd Gull, Jim Brown, Joshua Foukas, Kevin Guest, Myron W Wentz, Paul A Jones, Robert A Sinnott, Robert Auciaux and Walter Noot. View Institutional Ownership Trends for USANA Health Sciences.

Which major investors are selling USANA Health Sciences stock?

USNA stock was sold by a variety of institutional investors in the last quarter, including First Quadrant L P CA, Robeco Institutional Asset Management B.V., Virginia Retirement Systems ET AL, Systematic Financial Management LP, Dupont Capital Management Corp, Hancock Whitney Corp, Ifrah Financial Services Inc. and Louisiana State Employees Retirement System. Company insiders that have sold USANA Health Sciences company stock in the last year include Feng Peng, Frederic J Winssinger, G Doug Iiekking, Gilbert A Fuller, Global Ltd Gull, Joshua Foukas, Kevin Guest, Myron W Wentz, Robert Auciaux and Walter Noot. View Insider Buying and Selling for USANA Health Sciences.

Which major investors are buying USANA Health Sciences stock?

USNA stock was purchased by a variety of institutional investors in the last quarter, including State of New Jersey Common Pension Fund D, 6 Meridian, Comerica Bank, State of Tennessee Treasury Department, 6 Meridian, Rhumbline Advisers, California Public Employees Retirement System and First Trust Advisors LP. Company insiders that have bought USANA Health Sciences stock in the last two years include Global Ltd Gull and Myron W Wentz. View Insider Buying and Selling for USANA Health Sciences.

How do I buy shares of USANA Health Sciences?

Shares of USNA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is USANA Health Sciences' stock price today?

One share of USNA stock can currently be purchased for approximately $71.85.

How big of a company is USANA Health Sciences?

USANA Health Sciences has a market capitalization of $1.56 billion and generates $1.19 billion in revenue each year. The company earns $126.22 million in net income (profit) each year or $5.16 on an earnings per share basis. USANA Health Sciences employs 1,911 workers across the globe.View Additional Information About USANA Health Sciences.

What is USANA Health Sciences' official website?

The official website for USANA Health Sciences is http://www.usana.com/.

How can I contact USANA Health Sciences?

USANA Health Sciences' mailing address is 3838 West Parkway Blvd, Salt Lake City UT, 84120. The company can be reached via phone at 801-954-7100 or via email at [email protected]


MarketBeat Community Rating for USANA Health Sciences (NYSE USNA)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  305 (Vote Outperform)
Underperform Votes:  401 (Vote Underperform)
Total Votes:  706
MarketBeat's community ratings are surveys of what our community members think about USANA Health Sciences and other stocks. Vote "Outperform" if you believe USNA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe USNA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel